H Engler
- Co-authors
- Wolfram BruggerStefan W. KrauseReinhard AndreesenCarmen ScheibenbogenH.-G. LeserH.G. MeerpohlG. W. LöhrIstvan Szelenyi
- Topics
- Virus-based gene therapy research (5 papers)Cancer Research and Treatments (3 papers)RNA Interference and Gene Delivery (3 papers)
- Cited by
- ImmunologyBiotechnologyOncology
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
H Engler
18 papers receiving 405 citations
Peers
Comparison fields: 5 of 70
- Immunology 162
- Molecular Biology 152
- Oncology 123
- Genetics 113
- Surgery 91
Countries citing papers authored by H Engler
This map shows the geographic impact of H Engler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Engler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Engler more than expected).
Fields of papers citing papers by H Engler
This network shows the impact of papers produced by H Engler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Engler. The network helps show where H Engler may publish in the future.
Co-authorship network of co-authors of H Engler
This figure shows the co-authorship network connecting the top 25 collaborators of H Engler. A scholar is included among the top collaborators of H Engler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Engler. H Engler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 5 | |
| 3 | 39 | |
| 4 | A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth. | 20 |
| 5 | p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. | 79 |
| 6 | 2 | |
| 7 | A new approach to adoptive immunotherapy of cancer using tumorcytotoxic macrophages grown from peripheral blood monocytes. | 11 |
| 8 | Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. | 170 |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 32 | |
| 12 | 13 | |
| 13 | 17 | |
| 14 | Pirenzepine inhibits acid and pepsinogen secretion by the isolated perfused mouse stomach. | 5 |
| 15 | [Synthesis and h2-antihistaminic activity of n,n'-bisimidazole-substituted thioureas, cyanoguanidines and 2-nitro-1,1-ethenediamines 10. C: H2-antihistaminics]. | 1 |
| 16 | 1 | |
| 17 | 3 | |
| 18 | [Synthesis and H2-antihistaminic activity of ring methylated metiamide analogues. 4th communication: H2-antihistaminic agents (author's transl)]. | 1 |
About H Engler
H Engler is a scholar working on Pharmaceutical Science, Biotechnology and Genetics, having authored 18 papers that have together received 424 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), Cancer Research and Treatments (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Immunology (162 citations), Biotechnology (63 citations) and Oncology (123 citations). H Engler has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Wolfram Brugger, Stefan W. Krause, Reinhard Andreesen, Carmen Scheibenbogen, H.-G. Leser, H.G. Meerpohl, G. W. Löhr, Istvan Szelenyi, Daniel C. Maneval and Suganto Sutjipto. Their work appears in journals such as Cytokine & Growth Factor Reviews, Drug Metabolism and Disposition and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.